Quantbot Technologies’s Rhythm Pharmaceuticals RYTM Stock Holding History

Quantbot Technologies’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,363	Closed	-$119K	–	2205
2026 Q1	$119K	Buy	+1,363	New	+$133K	﹤0.01%	1290
2025 Q4	–	Sell	-4,981	Closed	-$503K	–	2106
2025 Q3	$503K	Buy	+4,981	New	+$462K	0.01%	1018
2024 Q2	–	Sell	-3,600	Closed	-$156K	–	1854
2024 Q1	$156K	Sell	3,600 -4,400	-55%	-$193K	0.01%	1071
2023 Q4	$368K	Buy	+8,000	New	+$252K	0.02%	824
2022 Q2	–	Sell	-2,538	Closed	-$29K	–	2073
2022 Q1	$29K	Buy	+2,538	New	+$22.3K	﹤0.01%	1305
2020 Q1	–	Sell	-1,463	Closed	-$33K	–	1312
2019 Q4	$33K	Buy	+1,463	New	+$32.5K	﹤0.01%	998
2018 Q3	–	Sell	-4,826	Closed	-$150K	–	1514
2018 Q2	$150K	Buy	+4,826	New	+$132K	0.01%	791

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quantbot Technologies's RYTM Position: Q2 2026 in Review

Quantbot Technologies sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 1,363 shares — an estimated $119K sold.

Quantbot Technologies first reported a position in RYTM in Q2 2018 and held it in 7 quarters. The position peaked at $503K in Q3 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Quantbot Technologies reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Quantbot Technologies sold 1,363 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $119K.
Quantbot Technologies first reported a position in Rhythm Pharmaceuticals in Q2 2018 and held it in 7 quarters.
Quantbot Technologies's Rhythm Pharmaceuticals position peaked at $503K in Q3 2025.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.